LAVERDIA-CA1

VERDINEXOR

Fight canine lymphoma with a pill

LAVERDIA-CA1
(verdinexor)
FDA Logo
Conditionally Approved Treatment
Trusted by

Primary Care Veterinarians & Oncologists

Pill bottle

Effective medicine for lymphoma patients
no matter where they are in the journey

Not Pursuing Chemotherapy
Just Diagnosed
Not Pursuing Chemotherapy
Using LAVERDIA-CA1 with or without prednisone can give you more healthy days with your dog than prednisone alone.
Waiting for First Appointment
Referred to Oncologist
Waiting for First Appointment
Canine lymphoma is aggressive. Use LAVERDIA-CA1 to help prevent the spread of cancer until chemotherapy can start.
Treatment Doesn't Have <span>to Stop</span>
Relapsed
Treatment Doesn't Have to Stop
LAVERDIA-CA1 is generally well tolerated, even by dogs that had to stop chemotherapy due to side effects.
If your dog has lymphoma
ask your veterinarian about LAVERDIA-CA1

Proven effective against B-cell and T-cell lymphoma

Not Cytotoxic

Not Injectable

Not Bone Marrow Suppressive

For Use: Prior to chemotherapy, with or without prednisone, or when relapse occurs.

Woman petting dog on mountain overlooking lake and forest

Spend more quality time together.

The world's first targeted lymphoma treatment in pill form that makes it possible for you to -

Treat your dog
anywhere.

Laverdia Pill bottles

LAVERDIA-CA1

Spend more time living together.

primary icon

Convenient

Treat your dog in the comfort of home
primary icon

Affordable

Priced to make treatment possible for more pets
primary icon

Safe

Studies show only mild or moderate side effects
primary icon

Targeted

Protects tumor suppressor proteins to cause cell death
primary icon

Effective

Fights even the most aggressive lymphomas
Manageable Side Effects

The most common side effects - anorexia, diarrhea, lethargy, weight loss, vomiting - are mild to moderate and effectively managed with supportive care. Check with your veterinarian to determine which treatment option is best for your pet.

Hard on Cancer, Not on Your Dog

Dogs on treatment maintain quality of life and continue favorite activities. In clinical studies with more than 250 dogs, none discontinued treatment as a result of side effects.

This is an Innovation in the treatment of canine lymphoma

Awarded 30 patents
for novel technology

laverdia infographic

Breakthrough SINE technology works in the nucleus of cells to kill cancer before it can spread

Watch how-it-works
SINE <span>On-Demand CE</span>
SINE Technology
SINE On-Demand CE
Pet <span>Owner Resources</span>
Extends Life
Pet Owner Resources
Frequently <span>Asked Questions</span>
Laverdia-ca1
Frequently Asked Questions
Veterinary Resources
Extends Life
Veterinary Resources
Primary <span>Care Veterinarians</span>
Designed For
Primary Care Veterinarians
<span>LAVERDIA-CA1</span> O<span>n-Demand</span> CE
Extends Life
LAVERDIA-CA1 On-Demand CE
Patient Stories
Extends Life
Patient Stories

More from the Anivive Library

Start treating canine lymphoma patients today

Laverdia

LAVERDIA-CA1

verdinexor

Now available to
veterinarians